Perinatal lipid nutrition alters early intestinal development and programs the response to experimental colitis in young adult rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 6, 2010, Pages

  Innis, Sheila M ^a   Dai, Chuanbin ^a   Wu, Xiujuan ^a   Buchan, Alison M J ^a   Jacobson, Kevan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Arachidonic acid; Inflammatory bowel disease; Intestinal programming; Milk fatty acids; n 3 fatty acids; n 6 fatty acids

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; RAPESEED OIL; SAFFLOWER OIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALORIC INTAKE; CELL PROLIFERATION; COLITIS; COLON; CONTROLLED STUDY; FEMALE; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; LACTATION; LIPID DIET; MALE; MATERNAL NUTRITION; MILK; MORPHOLOGY; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRIORITY JOURNAL; PROGENY; RAT;

ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; COLITIS; COLON; DIETARY FATS; DINITROFLUOROBENZENE; FEMALE; INTESTINES; MALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PERMEABILITY; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 78649735738     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00258.2010     Document Type: Article

References (45)

1. Alessandri JM, Arfi TS, Thieulin C. The mucosa of the small intestine: development of cellular lipid composition during enterocyte differentiation and postnatal maturation. Reprod Nutr Dev 30: 551-576, 1990.
2. Aoudjit L, Potapov A, Takano T. Prostaglandin E2 promotes cell survival of glomerular epithelial cells via the EP4 receptor. Am J Physiol Renal Physiol 290: F1534-F1542, 2006.
3. Appleyard CB, Wallace JL. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol Gastrointest Liver Physiol 269: G119-G125, 1995.
4. Armitage E, Drummond HE, Wilson DC, Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 13: 1439-1447, 2001.
5. Arnott ID, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol 35: 1163-1169, 2000.
6. Brasitus TA, Dudeja PK. Regional differences in the lipid composition and fluidity of rat colonic brush border membranes. Biochim Biophys Acta 819: 10-17, 1985.
7. Braun J, Wei B. Body traffic: ecology, genetics, and immunity in inflammatory bowel disease. Annu Rev Pathol 2: 401-429, 2007.
8. Catassi C, Bonucci A, Coppa GV, Carlucci A, Giorgi PL. Intestinal permeability changes during the first month: effect of natural versus artificial feeding. J Pediatr Gastroenterol Nutr 21: 383-386, 1995.
9. Chapman-Kiddell CA, Davies PS, Gillen L, Radford-Smith GL. Role of diet in the development of intestinal inflammatory bowel disease. Inflamm Bowel Dis 16: 137-51, 2010.
10. Cottrell EC, Ozanne SE. Early life programming of obesity and metabolic disease. Physiol Behav 94: 17-28, 2008.
11. D'Inca R, Di Leo V, Corrao G, Martines D, D'Odorico A, Mestriner C, Venturi C, Longo G, Sturniolo GC. Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 94: 2956-2960, 1999.
12. Ferraris RP. Dietary and developmental regulation of intestinal sugar transport. Biochem J 360: 265-276, 2001.
13. Fries W, Renda MC, Lo Presti MA, Raso A, Orlando A, Oliva L, Giofre MR, Maggio A, Mattaliano A, Macaluso A, Cottone M. Intestinal permeability and genetic determinants in patients, first-degree relatives, and controls in a high-incidence area of Crohn's disease in Southern Italy. Am J Gastroenterol 100: 2730-2736, 2005.
14. Galeazzi F, Blennerhassett PA, Qiu B, O'Byrne PM, Collins SM. Cigarette smoke aggravates experimental colitis in rats. Gastroenterology 117: 877-883, 1999.
15. Gookin JL, Galanko JA, Blikslager AT, Argenzio R. PG-mediated closure of paracellular pathway and not restitution is the primary determinant of barrier recovery in acutely injured porcine ileum. Am J Physiol Gastrointest Liver Physiol 285: G967-G979, 2003.
16. Holmes JL, Van Itallie CM, Rasmussen JE, Anderson JM. Claudin profiling in the mouse during postnatal intestinal development and along the gastrointestinal tract reveals complex expression patterns. Gene Expr Patterns 6: 581-585, 2006.
17. Innis SM, King DJ. trans Fatty acids in human milk are inversely associated with concentrations of essential all-cis n-6 and n-3 fatty acids and determine trans, but not n-6 and n-3, fatty acids in plasma lipids of breast-fed infants. Am J Clin Nutr 70: 383-390, 1999.
18. Innis SM, de la Presa Owens S. Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J Nutr 131: 118-122, 2001.
19. Innis SM, Dyer RA. Brain astrocyte synthesis of docosahexaenoic acid from n-3 fatty acids is limited at the elongation of docosapentaenoic acid. J Lipid Res 43: 1529-1536, 2002.
20. Innis SM. Polyunsaturated fatty acids in human milk: an essential role in infant development. Adv Exp Med Biol 554: 27-43, 2004.
21. Innis SM. Essential fatty acid transfer and fetal development. Placenta 26: S70-S75, 2005.
22. Jackson AA. Nutrients, growth, and the development of programmed metabolic function. Adv Exp Med Biol 478: 41-55, 2000.
23. Jacobsen BA, Fallingborg J, Rasmussen HH, Nielsen KR, Drewes AM, Puho E, Nielsen GL, Sorensen HT. Increase in incidence and prevalence of inflammatory bowel disease in northern Denmark: a population-based study, 1978-2002. Eur J Gastroenterol Hepatol 18: 601-606, 2006.
24. Jacobson K, Mundra H, Innis SM. Intestinal responsiveness to experimental colitis in young rats is altered by maternal diet. Am J Physiol Gastrointest Liver Physiol 289: G13-G20, 2005.
25. Jiang GL, Nieves A, Im WB, Old D, Dinh D, Wheeler L. The prevention of colitis by E Prostanoid receptor 4 agonist through enhancement of epithelium survival and regeneration. J Pharmacol Exp Ther 320: 22-28, 2007.
26. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, Narumiya S. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest 109: 883-893, 2002.
27. Kelly D, King T, Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 622: 58-69, 2007.
28. Lakatos L, Lakatos PL. Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe? Postgrad Med J 82: 332-337, 2006.
29. Langley-Evans SC. Developmental programming of health and disease. Proc Nutr Soc 65: 97-105, 2006.
30. Laukoetter MG, Nava P, Nusrat A. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol 14: 401-407, 2008.
31. Martin-Venegas R, Roig-Perez S, Ferrer R, Moreno JJ. Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation. J Lipid Res 47: 1416-1423, 2006.
32. Morelli L. Postnatal development of intestinal microflora as influenced by infant nutrition. J Nutr 138: 1791S-1795S, 2008.
33. Morteau O, Morham SG, Sellon R, Dieleman L, Langenbach R, Smithies O, Sartor RB. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest 105: 469-478, 2000.
34. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 27: 609-614, 1992.
35. Nusrat A, Turner JR, Madara JL. Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. Am J Physiol Gastrointest Liver Physiol 279: G851-G857, 2000.
36. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt P, Stobberingh E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118: 511-521, 2006.
37. Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 102: 1077-1083, 2007.
38. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 33: 687-693, 1992.
39. Rakoff-Nahoum S, Medzhitov R. Prostaglandin-secreting cells: a portable first aid kit for tissue repair. J Clin Invest 117: 83-86, 2007.
40. Schmidt C, Stallmach A. Etiology and pathogenesis of inflammatory bowel disease. Minerva Gastroenterol Dietol 51: 127-145, 2005.
41. Sheibanie AF, Yen JH, Khayrullina T, Emig F, Zhang M, Tuma R, Ganea D. The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis. J Immunol 178: 8138-8147, 2007.
42. Tanaka K, Suemasu S, Ishihara T, Tasaka Y, Arai Y, Mizushima T. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis. Eur J Pharmacol 603: 120-132, 2009.
43. Tsironi E, Feakins RM, Probert CS, Rampton DS, Phil D. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 99: 1749-1755, 2004.
44. Welcker K, Martin A, Kolle P, Siebeck M, Gross M. Increased intestinal permeability in patients with inflammatory bowel disease. Eur J Med Res 9: 456-460, 2004.
45. Wu X, Vallance BA, Boyer L, Bergstrom KSB, Walker J, Madsen K, O'Kusky JR, Buchan AM, Jacobson K. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 294: G295-G306, 2008.